Schizophrenia patients with a metabolically abnormal obese phenotype have milder negative symptoms

BMC Psychiatry

Table 3 The correlation between the MS components and diabetes related indicators in patients with schizophrenia (N = 329)

	Glucose	Insulin	C-peptide	Glucagon	HOMA-IR
BMI	0.121^*	0.477^***	0.482^***	0.295^***	0.475^***
Glucose	–	0.159^**	0.131^*	0.047	0.412^***
Cholesterol	0.120^*	0.183^***	0.150^**	0.073	0.206^***
Triglycerides	0.169^**	0.395^***	0.360^***	0.248^***	0.403^***
HDL _C	−0.095	−0.162^**	−0.221^***	− 0.190^***	−0.174^**
LDL_C	0.160^**	0.171^**	0.136^*	0.081	0.208^***
SBP	0.024	0.143^**	0.163^**	0.101	0.151^**
DBP	−0.011	0.176^***	0.225^***	0.172^**	0.179^***

Spearman correlation was used for statistical analysis. The data in the table was correlation coefficients and the asterisk indexed significant. BMI Body mass index, HDL_C High-density lipoprotein cholesterol, LDL_C Low-density lipoprotein cholesterol, SBP Systolic blood pressure, DBP Diastolic blood pressure, HOMA-IR Homeostasis model assessment of insulin resistance
^*P < 0.05
^**P < 0.01
^***P < 0.001

ISSN: 1471-244X